Clinical Trial

Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated November 27, 2024 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to evaluate the effectiveness of nebulized magnesium sulfate combined with sildenafil citrate, compared with sildenafil citrate alone, in treating neonates with severe persistent pulmonary hypertension on mechanical ventilation.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-05-21; most recent amendment 2024-11-26.
Status change: Not Yet Recruiting → Recruiting 2021-06-05
Trial Details
NCT Number NCT04898114
Lead Sponsor Sohag University
Conditions Persistent Pulmonary Hypertension of Newborn
Enrollment 40 participants
Start Date 2021-06-02
Primary Completion 2025-04-30 (estimated)
Study Completion 2025-06-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-27